Bosnia and Herzegovina vs Latvia: Proportion of bloodstream infection due to Escherichia coli resistant
Bosnia and Herzegovina
22.3%
in 2023
Latvia
22.9%
in 2023
Bosnia and Herzegovina rank
39th
Latvia rank
37th
Proportion of bloodstream infection due to Escherichia coli resistant over time
- Bosnia and Herzegovina
- Latvia
How they compare
Latvia currently reports 22.9% against 22.3% in Bosnia and Herzegovina, a difference of 0.6%.
The two have swapped places 6 times across 8 shared years of data; in 2016 it was Latvia ahead.
Bosnia and Herzegovina ranks 39th and Latvia ranks 37th of 58 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.0% | 21.2% | 0.9% | Bosnia and Herzegovina |
| 2020s | 25.4% | 22.8% | 2.5% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to escherichia coli resistant, Bosnia and Herzegovina or Latvia?
- Latvia, at 22.9% against 22.3% in Bosnia and Herzegovina as of 2023.
- What is the difference in proportion of bloodstream infection due to escherichia coli resistant between Bosnia and Herzegovina and Latvia?
- 0.6%, with Latvia ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Latvia?
- 8 years are reported by both, from 2016 to 2023.
- How do Bosnia and Herzegovina and Latvia rank globally for proportion of bloodstream infection due to escherichia coli resistant?
- Bosnia and Herzegovina ranks 39th and Latvia ranks 37th of 58 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.